UNSPSC 51393606: Indacaterol maleate

This classification denotes a beta-adrenergic agonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2JEC1ITX7R. European Medicines Agency schedules Indacaterol maleate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB30300. Indacaterol maleate generally arises in the molecular formula C24H28N2O3.C4H4O4. The term 'indacaterol maleate' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule indacaterol maleate under HS 29337900 and SITC 51561.

As of Q4 2014, INDACATEROL MALEATE remains US FDA's Preferred Term for this commodity. Indacaterol maleate bears US NLM identifiers UMLS ID C2920417 and NCI Concept Code C81640. SMILES: CCC1CC2C(CC1CC)CC(C2)NC[C@@H](C3CCC(C4C3CCC(=O)[NH]4)O)O.C(=C\C(=O)O)\C(=O)O.

UNSPSC 51393606 Indacaterol maleate, a Commodity code, represents pharmaceutical inhalation products procured by state and local health agencies, though recent opportunities tagged under this code show a significant mismatch between the code's nominal scope and actual buying activity. The single substantive state-local solicitation on record—Seminole County, Florida's IFB60459723LAS for Naloxone and Safe Drug Deactivation Systems—involves emergency-response medications and harm-reduction equipment rather than indacaterol maleate, a long-acting bronchodilator used in chronic obstructive pulmonary disease treatment. This tagging anomaly suggests either a data-classification error or an overly broad code assignment by the issuing body. The Texas Health and Human Services Commission's RFI HHS0017013 for Direct-to-Manufacturer Prescriptions is exploratory in nature and does not specify pharmaceutical commodities, making it unsuitable for vendor strategy purposes at this stage.

Seminole County's naloxone procurement, posted June 30, 2026, with a response deadline of July 26, 2023, sought 1,900 units annually through electronic submission, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, and a two-year initial term plus one-year renewal option. The opportunity required E-Verify compliance, drug-free workplace certification, and standard insurance coverage (workers' compensation, commercial general liability, professional liability), with potential FEMA funding and attendant federal compliance requirements. Beyond this single relevant opportunity, the code shows minimal recent state and local procurement activity. Business development professionals should treat this code with caution: the current opportunity base is sparse, the recent tagging accuracy is questionable, and pursuing this category requires direct engagement with county health procurement offices to identify authentic indacaterol maleate demand outside the mislabeled opportunities currently visible.